Pharmafile Logo

Inizio leaders featured in Forbes’ ‘Voices of Oncology’ to drive innovation in cancer care

September 24, 2025 |  

Inizio experts contribute to Forbes’ Voices of Oncology, highlighting our commitment to driving innovation in cancer care through advanced data analytics, cross-sector collaboration, and real-world impact for patients.

Voices-of-Oncology-Inizio

With over 30 years of deep-rooted expertise in oncology, we partner with our clients at each pivotal moment in their journey, unlocking value through a connected suite of capabilities. Today, we’re proud to announce that a number of our leaders in Inizio have been featured in Forbes’ Voices of Oncology, a collaboration that reflects our commitment to advancing cancer care.

Launching September 9, the ‘Voice of Innovation Partners’ chapter in Forbes’ ‘Voices of Oncology’ features contributions from:

Accelerating innovation in oncology through collaboration, data & technology

The ‘Voice of Innovation Partners’ chapter explores how innovation partners like Inizio harness advanced data analytics, cutting-edge technology, and cross-sector collaboration to:

  • Simplify complex challenges in oncology
  • Enhance decision-making across the cancer care continuum
  • Improve patient outcomes through real-world impact

The book is a powerful collection of insights from global experts and thought leaders, offering a shared perspective on how we can work better together to shape the future of oncology. Voices of Oncology is an initiative of the Oncology Voice Network (OVN), a new platform built to spark connection, share knowledge, and amplify solutions across pharma, biotech, academia, and patient advocacy.

Pre-order now: Forbes’ Voices of Oncology

Available to pre-order now via Amazon – explore the Voices of Oncology here. If you’re looking for a partner who can turn knowledge into action and accelerate the journey from breakthrough science to real-world impact, learn more about us.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Sabera Hyderally appointed Head of MedTech North America

Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.

Full speed ahead: Unlock the full potential of your brand tracking

Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST

How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market

Our client was developing a new drug aimed at first line NSCLC patients. Ahead of its launch they wanted to assess likely uptake in an already fragmented market space led...

Research Partnership and Janssen are 2017-18 BOBI Awards finalists

We are delighted to announce that an entry submitted by Research Partnership with Janssen has been selected as a finalist in the Best Business Impact category at this year’s BOBI...

Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio

Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST

PMRC New Jersey round up 2018

Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey

Bringing sufferers out of the shadows – Reducing the emotional impact of living with Atopic Dermatitis

You can probably remember at least one of your friends in school who was always scratching and suffered from red, scaly skin rashes, perhaps on their elbows or backs of...

Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean

In the second of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Latin America and the Caribbean

How we applied user-led design thinking in the ER setting to improve patient care

The challengeOur client needed to identify the key delivery-device attributes for an antibiotic topical treatment used to combat a group of infections typically affecting young children. Current treatment is a...

Research conducted by Research Partnership published in leading medical journal

Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal